Medi-Clinic /Nozala/Mvelaphanda - Announcement
Medi-Clinic Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
Share Code: MDC
ISIN: ZAE000004370
("Medi-Clinic")
Nozala Investments (Proprietary) Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1996/004733/07
("Nozala")
Mvelaphanda Capital (Proprietary) Limited
(Incorporated in the Republic of South Africa)
(Registration number: 2002/003564/07)
("Mvelaphanda")
Acquisition by Medi-Clinic, Nozala, Mvelaphanda and Utlwanang
of 67,09% of the shares in Curamed Holdings Limited ("Curamed")
Medi-Clinic, in conjunction with Nozala Mvelaphanda and Utlwanang (a consortium
of medical professionals from previously disadvantaged communities) is proud to
announce the acquisition of a 67,09% interest in Curamed. Joining forces with
empowerment partners Nozala, Mvelaphanda and Utlwanang this transaction embodies
the commitment of Medi-Clinic to share its knowledge and expertise in a
meaningful and significant manner.
Curamed is a group of six Pretoria-based specialist hospitals comprising 706
beds. The investment will expand the Medi-Clinic group`s proven ability to
provide quality healthcare and it will also support the further development of
the business environment in Pretoria.
Medi-Clinic, Nozala, Mvelaphanda and Utlwanang will work together to empower and
enhance private healthcare in this attractive environment.
The transaction is subject to the approval of the Competition Authorities.
Stellenbosch
30 October 2002
For more information see www.mediclinic.co.za
Sponsor Attorneys
Rand Merchant Bank Hofmeyr
Date: 30/10/2002 04:00:00 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
